🎁 Black Friday: up to 50% off of annual plans
Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.39
-0.48 (-5.41%)
At close: Nov 20, 2026, 4:00 PM EST
8.30
-0.09 (-1.05%)
After-hours: Nov 20, 2026, 7:30 PM EST

Vir Biotechnology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
218.87232.19222.95241.58848.63347.82
Short-Term Investments
239.49234.83682.41,2811,553360.33
Cash & Short-Term Investments
458.36467.02905.351,5222,402708.15
Cash Growth
-9.51%-48.42%-40.53%-36.62%239.20%-3.90%
Accounts Receivable
-----773.08
Other Receivables
5.43.6511.628.9-
Receivables
5.43.6511.628.9773.08
Prepaid Expenses
42.5841.5442.7340.9557.8473
Restricted Cash
1.931.9289.3913.2712.688.59
Other Current Assets
----17.62-
Total Current Assets
508.27514.081,0421,5882,5191,563
Property, Plant & Equipment
105.76117.72122.86167.2188.17130.05
Long-Term Investments
442.93314.58190.02105.2823.93201.39
Goodwill
16.9416.9416.9416.9416.9416.94
Other Intangible Assets
7.637.858.1222.5732.7633.29
Other Long-Term Assets
30.3231.6618.4218.8621.239.78
Total Assets
1,1121,0031,3991,9192,8021,954

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
11.329.85.086.336.426.52
Accrued Expenses
58.1872.3966.5382.15462.07129.54
Current Portion of Leases
9.328.87.7512.874.143.93
Current Income Taxes Payable
----15.236.22
Current Unearned Revenue
--12.6564.8515.5298.21
Other Current Liabilities
1.841.8327.659.27.6596.83
Total Current Liabilities
80.6692.82119.66175.41511.03341.24
Long-Term Leases
81.4689.0590.14111.67123.84133.56
Long-Term Unearned Revenue
----53.213.82
Long-Term Deferred Tax Liabilities
-----18.44
Other Long-Term Liabilities
53.755.6838.6341.7436.0525.36
Total Liabilities
215.82237.55248.43328.82724.13522.42

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.010.010.010.010.01
Additional Paid-In Capital
2,2431,9651,9121,8291,7101,572
Retained Earnings
-1,340-1,198-759.78-237.82377.24-138.6
Comprehensive Income & Other
-6.9-2.06-1.72-0.82-9.12-1.1
Total Common Equity
896.04765.281,1501,5902,0781,432
Shareholders' Equity
896.04765.281,1501,5902,0781,432
Total Liabilities & Equity
1,1121,0031,3991,9192,8021,954

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
90.7897.8597.89124.54127.97137.49
Net Cash (Debt)
367.58369.16807.461,3982,274570.66
Net Cash Growth
-9.54%-54.28%-42.24%-38.53%298.50%-14.40%
Net Cash Per Share
2.362.675.9310.4216.874.28
Filing Date Shares Outstanding
171.27139.52137.14135.03133.53132.3
Total Common Shares Outstanding
169.41139.47136.96134.78133.24131.16
Working Capital
427.61421.27922.81,4132,0081,222
Book Value Per Share
5.295.498.4011.8015.6010.92
Tangible Book Value
871.47740.491,1251,5512,0281,382
Tangible Book Value Per Share
5.145.318.2211.5115.2210.53
Machinery
46.846.4944.949.441.9322.57
Construction In Progress
-0.111.070.23-26.93
Leasehold Improvements
56.2956.1853.9980.2984.427.83
SEC Filings: 10-K · 10-Q